UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$456M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$403M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$391M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$381M |
| 5 |
UnitedHealth
UNH
|
+$355M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$3.79B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$626M |
| 3 |
Microsoft
MSFT
|
+$596M |
| 4 |
Johnson & Johnson
JNJ
|
+$307M |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$256M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.25% |
| 2 | Financials | 6.72% |
| 3 | Healthcare | 6.58% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 4.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4426
Pathward Financial
CASH
$1.81B
| $807K | ﹤0.01% |
17,416
-4,920
| -22% | -$221K |
|
4427
Nurix Therapeutics
NRIX
$2.69B
| $806K | ﹤0.01% |
80,647
-4,461
| -5% | -$45.5K |
|
4428
Blue Bird Corp
BLBD
$2.07B
| $805K | ﹤0.01% |
35,797
+32,747
| +1,074% | +$701K |
|
4429
First Trust Multi Cap Growth AlphaDEX Fund
FAD
$591M
| $804K | ﹤0.01% |
7,618
-528
| -6% | -$52.2K |
|
4430
Equinox Gold
EQX
$13.5B
| $804K | ﹤0.01% |
175,453
+38,493
| +28% | +$193K |
|
|
PMF
4431
DELISTED
PIMCO Municipal Income Fund
PMF
| $803K | ﹤0.01% |
78,097
-79,171
| -50% | -$791K |
|
|
PNF
4432
DELISTED
PIMCO New York Municipal Income Fund
PNF
| $802K | ﹤0.01% |
93,445
-1,626
| -2% | -$14.1K |
|
|
NXGN
4433
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $801K | ﹤0.01% |
49,380
+19,382
| +65% | +$321K |
|
4434
Cerus
CERS
$508M
| $800K | ﹤0.01% |
325,398
+124,573
| +62% | +$296K |
|
4435
Crescent Energy
CRGY
$4.03B
| $800K | ﹤0.01% |
76,747
-1,097
| -1% | -$11.7K |
|
4436
First Trust Dow Jones Select MicroCap Index Fund
FDM
$269M
| $797K | ﹤0.01% |
14,170
-2,717
| -16% | -$145K |
|
4437
State Street SPDR Portfolio Mortgage Backed Bond ETF
SPMB
$7.03B
| $796K | ﹤0.01% |
36,334
-136,748
| -79% | -$3.01M |
|
4438
James River Group Holdings
JRVR
$210M
| $794K | ﹤0.01% |
43,509
+12,719
| +41% | +$253K |
|
4439
Core Laboratories
CLB
$561M
| $794K | ﹤0.01% |
34,137
+23,136
| +210% | +$523K |
|
|
GOLD
4440
Gold.com Inc
GOLD
$1.26B
| $793K | ﹤0.01% |
21,192
+4,925
| +30% | +$178K |
|
4441
Kenon Holdings
KEN
$3.35B
| $793K | ﹤0.01% |
34,132
-31,275
| -48% | -$841K |
|
4442
PUT
Bunge Global
BG
$21.6B
| $793K | ﹤0.01% |
+8,400
| New | +$780K |
|
4443
Saia
SAIA
$9.49B
| $792K | ﹤0.01% |
2,313
+1,083
| +88% | +$313K |
|
4444
Origin Bancorp
OBK
$1.64B
| $789K | ﹤0.01% |
26,940
-2,402
| -8% | -$71.9K |
|
4445
CALL
Centene
CNC
$32.9B
| $789K | ﹤0.01% |
11,700
-13,300
| -53% | -$887K |
|
4446
Cushman & Wakefield Ltd
CWK
$3.12B
| $788K | ﹤0.01% |
96,341
+50,837
| +112% | +$442K |
|
4447
argenx
ARGX
$54.2B
| $788K | ﹤0.01% |
2,021
+488
| +32% | +$192K |
|
|
CTLP
4448
DELISTED
Cantaloupe
CTLP
| $785K | ﹤0.01% |
98,641
+77,908
| +376% | +$505K |
|
|
LAND
4449
Gladstone Land Corp
LAND
$351M
| $785K | ﹤0.01% |
48,250
+5,429
| +13% | +$87.9K |
|
4450
Karyopharm Therapeutics
KPTI
$44.4M
| $783K | ﹤0.01% |
29,174
+18,345
| +169% | +$790K |
|
Similar funds
UBS Group's Q2 2023 Portfolio in Review
As of Q2 2023, UBS Group held 10,482 positions worth $296B, up 8.2% from $274B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group's Q2 2023 filing shows 945 new, 3,995 increased, 3,455 reduced and 1,657 closed positions. Its largest new stake was Global X Emerging Markets Great Consumer ETF: 1,048,148 shares worth $26.1M. The largest sale was UBS Group, an estimated $3.79B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2023 buy was Global X Emerging Markets Great Consumer ETF: 1,048,148 shares worth $26.1M.
- UBS Group added most to State Street Financial Select Sector SPDR ETF in Q2 2023, an estimated $456M increase.
- UBS Group's biggest Q2 2023 reduction was UBS Group, cutting an estimated $3.79B.
- UBS Group fully exited DCP Midstream, LP in Q2 2023, selling an estimated $148M.
- UBS Group's ten largest holdings make up 14% of its $296B portfolio in Q2 2023.
- UBS Group opened 945 new positions and closed 1,657 in Q2 2023.
- UBS Group's portfolio value rose 8.2% quarter-over-quarter to $296B.
Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.